metoclopramide and chitosan

metoclopramide has been researched along with chitosan in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anguiano-Igea, S; Blanco Méndez, J; Ganza-González, A; Otero-Espinar, FJ1
Cossu, M; Gavini, E; Giunchedi, P; Rassu, G; Sanna, V1
Abd ElHady, SS; Awad, GA; Mortada, ND; Zaki, NM1
Cossu, M; Gavini, E; Giunchedi, P; Muzzarelli, C; Rassu, G1
Arora, A; Goel, H; Rana, V; Tiwary, AK1
Abbas, G; Bernkop-Schnürch, A; Hanif, M; Jalil, A; Sharif, S; Yaqoob, M1

Other Studies

6 other study(ies) available for metoclopramide and chitosan

ArticleYear
Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 1999, Volume: 48, Issue:2

    Topics: Administration, Oral; Antiemetics; Biocompatible Materials; Chemistry, Pharmaceutical; Chitin; Chitosan; Chondroitin Sulfates; Delayed-Action Preparations; Hydrogen-Ion Concentration; Kinetics; Metoclopramide; Microscopy, Electron, Scanning; Microspheres; Particle Size

1999
Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:3

    Topics: Adhesiveness; Adhesives; Administration, Intranasal; Alginates; Animals; Antiemetics; Chitosan; Delayed-Action Preparations; Glucuronic Acid; Hexuronic Acids; In Vitro Techniques; Metoclopramide; Microspheres; Nasal Mucosa; Particle Size; Permeability; Sheep

2005
Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    International journal of pharmaceutics, 2006, Dec-11, Volume: 327, Issue:1-2

    Topics: Absorption; Administration, Intranasal; Animals; Antiemetics; Biological Availability; Chitosan; Deoxycholic Acid; Erythrocytes; Hemolysis; Humans; L-Lactate Dehydrogenase; Male; Metoclopramide; Nasal Lavage Fluid; Nasal Mucosa; Peptides; Protamines; Proteins; Rats; Rats, Inbred Strains; Sodium Cholate

2006
Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2008, Volume: 68, Issue:2

    Topics: Administration, Intranasal; Animals; Antiemetics; Chitosan; Drug Carriers; Hydrogels; Metoclopramide; Microscopy, Electron, Scanning; Microspheres; Pyrrolidinones; Sheep

2008
Development and evaluation of mathematical model to predict disintegration time of fast disintegrating tablets using powder characteristics.
    Pharmaceutical development and technology, 2011, Volume: 16, Issue:1

    Topics: Adsorption; Chemistry, Pharmaceutical; Chitosan; Compressive Strength; Domperidone; Drug Stability; Excipients; Glycine; Metoclopramide; Models, Chemical; Ondansetron; Powders; Solubility; Tablets; Time Factors; Water

2011
Mucoadhesive micro-composites: Chitosan coated halloysite nanotubes for sustained drug delivery.
    Colloids and surfaces. B, Biointerfaces, 2019, Dec-01, Volume: 184

    Topics: Adhesiveness; Chitosan; Drug Delivery Systems; Drug Liberation; Humans; Intestinal Mucosa; Metoclopramide; Nanotubes; Particle Size; Porosity; Surface Properties

2019